Science Pool

Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies

Evotec SE today announced that the Company has joined forces with the Crohn’s & Colitis Foundation (“the Foundation”), the leading non-profit organisation focused on both research and patient support for inflammatory bowel disease (“IBD”), which includes Crohn’s disease and ulcerative colitis. 

Read More